Login / Signup

Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.

Hyo Jung ParkLei QinZiad BakounyKatherine M KrajewskiEliezer M Van AllenToni K ChoueiriAtul B Shinagare
Published in: The oncologist (2022)
CT texture analysis performed at baseline and early after starting PD-1/PD-L1 inhibitors is associated with clinical outcomes of patients with mRCC.
Keyphrases
  • computed tomography
  • contrast enhanced
  • metastatic renal cell carcinoma
  • magnetic resonance imaging
  • dual energy
  • image quality
  • magnetic resonance